• Allaart, C., Poort, S., Rosendaal, F., Reitsman, P., Bertina, R. & Briet, E. (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet, 341, 134138.
  • Baglin, C., Brown, K., Luddington, R. & Baglin, T. (1998) Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation. effect of warfarin and prediction by precipitating factors. British Journal of Haematology, 100, 764768.
  • British Committee for Standards in Haematology. (1998) Guidelines on oral anticoagulation, 3rd edn. British Journal of Haematology, 101, 374387.
    Direct Link:
  • Clinical Synthesis Panel on HRT. (1999) Hormone replacement therapy. Lancet, 354, 152155.
  • De Stefano, V., Martinelli, I., Mannucci, P.M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E. & Leone, G. (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. New English Journal of Medicine, 341, 801806.
  • Eichinger, S., Pabinger, I., Stumpflen, A., Hirschl, M., Bialonczyk, C., Schneider, B., Mannhalter, C., Minar, E., Lechner, K. & Kyrle, P.A. (1997) The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thrombosis and Haemostasis, 77, 624628.
  • Greaves, M. (1999) Antiphospholipid antibodies and thrombosis. Lancet, 353, 13481353.
  • Hellgren, M., Svensson, P.J. & Dahlback, B. (1995) Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. American Journal of Obstetrics and Gynecology, 173, 210213.
  • Kearon, C., Gent, M., Hirsh, J., Weitz, K., Kovacs, M., Anderson, D.R., Turpie, A.G., Green, D., Ginsberg, J.S., Wells, P., MacKinnon, B. & Julian, J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New English Journal of Medicine, 340, 901907.
  • Lindmarker, P., Schulman, S., Sten-Linder, M., Wiman, B., Egberg, N., Johnsson, H. and the DURAC Study Group. (1999) The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. Thrombosis and Haemostasis, 81, 684689.
  • Makris, M., Preston, F.E., Beauchamp, N.J., Cooper, P.C., Daly, M.E., Hampton, K.K., Bayliss, P., Peake, I.R., & Miller, G.J. (1997) Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thrombosis and Haemostasis, 78, 14261429.
  • Palareti, G., Manotti, C., D'angelo, A., Pengo, V., Erba, D., Moia, M., Ciavarella, N., Devoto, G., Berrettini, M. & Musolesi, S. (1996) Thrombotic events during oral anticoagulant treatment; results of the inception-cohort, prospective, collaborative ISCOAT study. Thrombosis and Haemostasis, 78, 13381343.
  • Prandoni, P., Lensing, A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattellan, A.M., Polistena, P., Bernardi, E. & Prins, M.H. (1996) The long-term clinical course of acute deep vein thrombosis. Annals of Internal Medicine, 125, 17.
  • Prandoni, P., Lensing, A.W.A., Prins, M.H., Bagatella, P., Scudeller, A. & Girolami, A. (1999) Which is the outcome of the post–thrombotic syndrome? Thrombosis and Haemostasis, 82, 1358.
  • Preston, F.E. & Greaves, M. (1996) Laboratory diagnosis of hereditary thrombophilia. In: Hypercoagulable States. Fundamental Aspects, Acquired Disorders and Congenital Thrombophilia (ed. by M.J.Seghatchian, M.M.Samama & S.P. Hecker), pp. 7786. CRC Press.
  • Ridker, P., Miletich, J., Stampfer, M., Goldhaber, S., Lindpaintner, K. & Henekens, C. (1995) Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation, 92, 28002802.
  • Rintelen, C., Pabinger, I., Knobl, P., Lechner, K. & Mannhalter, C. (1996) Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thrombosis and Haemostasis, 75, 229232.
  • Rosendaal, F.R. (1996) Oral contraceptives and screening for factor V Leiden. Thrombosis and Haemostasis, 75, 524525.
  • Schulman, S. & Tengborn, L. (1993) Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III. Thrombosis and Haemostasis, 68, 634636.
  • Simioni, P., Prandoni, P., Lensing, A., Scudeller, A., Sardella, C., Prins, M., Villalata, S., Dazzi, F. & Girolami, A. (1997) The risk of recurrent venous thromboembolism in patients with an Arg506 to Gln mutation in the gene for factor V (factor V Leiden). New English Journal of Medicine, 336, 399403.
  • Tait, R.C., Walker, I.D., Islam, S.I.A.M., Mitchell, R. & Davidson, J.F. (1993) Protein C activity in healthy volunteers, influence of age, sex, smoking and oral contraceptives. Thrombosis and Haemostasis, 70, 281285.
  • Van Boven, H., Reitsma, P., Rosendaal, F., Bayston, T., Chowdhury, B., Bauer, K., Scharrer, I., Conard, J. & Lane, D.A. (1996) Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thrombosis and Haemostasis, 75, 417421.
  • Van Den Belt, A.G.M., Sanson, B.-J., Simioni, P., Prandoni, P., Buller, H.R., Girolami, A. & Prins, M.H. (1997) Recurrence of venous thromboembolism in patients with familial thrombophilia. Archives of Internal Medicine, 157, 22272232.
  • Vandenbroucke, J.P., Koster, T., Briet, E., Reitsma, P.H., Bertina, R.M. & Rosendaal, F.R. (1995) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 14531457.
  • Vandenbroucke, J.P., Van Der Meer, F.J.M., Helmerhorst, F.M. & Rosendaal, F.R. (1996) Factor V Leiden: should we screen oral contraceptive users and pregnant women? British Medical Journal, 313, 11271130.
  • Zoller, B., Berntsdotter A., Garcia de Frutos, P. & Dahlback, B. (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood, 85, 35183523.